(6R)-6-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (6R)-6-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
• 化学式: C₂₇H₄₄O₂
• 分子量: 400.6
• InChiKey: ORBBAHBRPFOVJO-HGUAUECJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.6
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Biomarkers for Fatty Liver Disease and Methods Using the Same
  申请人：Metabolon, Inc.

  公开号：US20170370954A1

  公开（公告）日：2017-12-28

  Biomarkers of NASH, NAFLD, and fibrosis and methods for diagnosis (or aiding in the diagnosis) of NAFLD, NASH and/or fibrosis are described herein. Additionally, methods of distinguishing between NAFLD and NASH, methods of classifying the stage of fibrosis, methods of determining the severity of liver disease, methods of determining the severity of liver disease or fibrosis, and methods of monitoring progression/regression of NASH, NAFLD, and/or fibrosis are described herein.
• [EN] LIPOSOMES COMPRISING ANTI-LOX ANTIBODY<br/>[FR] LIPOSOMES COMPRENANT UN ANTICORPS ANTI-LOX
  申请人：ISTITUTO SCIENT ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI I R S T S R L

  公开号：WO2021064076A1

  公开（公告）日：2021-04-08

  The present invention relates to a liposome comprising a poly(ethylene glycol)-lipid (PEG-lipid), cholesterol and an anti-LOX antibody and relative pharmaceutical formulation, medical uses in particular for the treatment of cancer.